EBOO /F is the most advanced minimally invasive intravenous therapies available to detox your blood. While there are a number of devices that can ozonate your blood in a precise and safe way, this is the only device that can actually filter your blood while it is being ozonated… and that is its greatest benefit.
Watch the video : How I Finally Healed from Lyme Disease – I Tried Everything!
What is EBOO /F Ozone Therapy (Apheresis)?
Invented in the 1980s, EBOO /F, also know as Recirculatory Hemoperfusion, Apheresis and Ozone Dialysis, is somewhat similar to dialysis, which filters out of your blood waste chemicals that healthy kidneys normally accomplish for you.
It is a process in which different constituents of the blood can be separated from one another and treated individually.
- Red blood cell
- White blood cells
- Plasma
- Platelets/Stem Cells
Various apheresis filters called dialyzers are engineered differently and from different materials in order to filter out specifically targeted elements. Historically, dialyzers were designed as a last resort to capture and remove excess lipids from patients at risk for cardiovascular failure, who did not respond to conventional therapy.
The EBOO /F is engineered to cleanse your blood of physical debris that your body is not capable of.
The body has two primary mechanisms for cleansing and detoxing your blood, your kidneys and liver. However they are not good at removing some specific toxic debris that make us very sick.
The EBOO /F is essential in that it is engineered to cleanse your blood of physical debris that neither the kidneys, nor liver, are capable of removing.
Explore the photos below to get an in-depth view of the EBOO /F (apheresis) device.
Why is the EBOO /F Filtration Important?
In cases of chronic infections, such as:
- Lyme Disease
- Candida
- Mold
- Viruses (yes, even Long Covid)
- Biofilm from bacteria and viruses
Other common blood toxins:
- Heavy metals
- Residuals for medications
- Environmental toxins – pesticides etc.
- Chemotherapy
- Industrial toxins
- Excessive and/or abnormal blood clotting
- Etc.
Even after the original pathogen has been killed, many patients still suffer debilitating symptoms that destroy their lives. Many Integrative physicians believe that this is due to residual “debris” left over from the infection. Endotoxins, cellular debris from dead pathogens, biofilm, micro clots, abnormal clotting (a characteristic of CV19 and LHC) and even debris from our own tissues damaged by the infection and the medications used to kill it. Our kidneys and liver are not designed to clear this debris, so it persists in our body as toxins that wreak havoc on us.
Debris being removed from the patient’s blood. This debris will be captured by the EBOO /F filter. The purified, debris-free blood is then re-infused back into the patient.
The EBOO /F filtration is designed to clear this debris. We can actually see the “gunk” being sucked out of these patients, and captured by the filter, allowing purified blood to be re-infused back into them.
The toxic blood comes out of one arm, goes through the EBOO device, is filtered and ozonated, then the cleansed and ozonated blood goes into the other arm.
Many report immediate relief from their symptoms… literally during their first treatment with EBOO /F.
Explore the photos below to get an in-depth view of the debris the EBOO /F (apheresis) removes from the blood.
What Conditions can Benefit from EBOO /F Ozone Therapy?
EBOO /F is used to aid a variety of chronic diseases including:
- Auto-immune Diseases
- Diabetes
- Long-Haul COVID
- Lyme Disease
- Herpes
- Hepatitis
- Brain fog
- Chronic fatigue states
- Chronic bladder conditions
- Colitis
- Crohn’s disease
- Stroke
- Hypertension
- Eczema and Psoriasis
- Lipid disorders
- Cardiovascular disease
- Peripheral Arterial Disease (PAD)
- Coronary Disease
- Severe Dyslipidemia
- Madelung Disease
- Necrotizing Fasciitis
EBOO /F Treatment and Long COVID
Depending on the severity of the typical COVID patient’s symptoms EBOO /F sessions will range from 1 – 10 treatments. Rarely will we need to go beyond 5 treatments.
Often “gunk” will be observed emerging within the flow of venous blood. “Gunk” will typically stop appearing by the third EBOO /F treatment. However, an IV chelation with disodium EDTA 1-2 days prior to the next EBOO /F treatment often releases additional “gunk”.
Explore the photos below to get an in-depth view of debris in the blood and the filter / dialyzer that removes it.
Lab Results – What the Dialyzer Removes from the Blood
Patient 1143 – Blood Pre-EBOO /F and Blood Post-EBOO /F
The photo on the left is of the patient’s blood prior to receiving the EBOO /F treatment. The center photo is of the used dialyzer. The photo on the right is of the patient’s blood immediately after the EBOO /F treatment.
Pre-EBOO /F
The 1st photo is an Advanced Stain at 100X. Structure observed is suggestive of biofilm, clots and extracellular traps.
The 2nd photo is of the patient’s used EBOO /F filter fibers. Giemsa Stain at 100X. Structures observed suggestive of biofilm, clot and extracellular traps adhered to EBOO /F filter fiber.
Post-EBOO /F
The 3rd photo is an Advanced Stain at 400X. Normal blood was observed. No structures suggestive of biofilm observed. Platelet clotting / micro-clotting not observed.
PATIENT 1143 : The patient’s blood before and after treatment with the EBOO /F device. The photo on the left is before the treatment. The center photo is of a fiber inside the patient’s used dialyzer. The photo on the right is the patient’s blood immediately after the treatment.
Patient 1144 – Blood Pre-EBOO /F and Blood Post-EBOO /F
The photo on the left is of the patient’s blood prior to receiving the EBOO /F treatment. The center photo is of the patient’s used EBOO /F dialyzer. The photo on the right is of the patient’s blood immediately after the EBOO /F treatment.
Pre-EBOO /F
The 1st photo is an Advanced Stain at 400X. Structures observed are suggestive of biofilm, clots and extracellular traps present. Yellow arrow indicated structure suggestive of bacteria.
The 2nd photo is of the patient’s used EBOO /F dialyzer. Giemsa Stain at 1000X. Structures suggestive of biofilm, clot and extracellular traps observed suspended between two EBOO /F filter filaments.
Post-EBOO /F
The 3rd photo is an Advanced Stain at 400X. Normal blood was observed. No structures suggestive of biofilm observed. Platelet clotting / micro-clotting not observed.
PATIENT 1144 : The patient’s blood before and after treatment with the EBOO /F device. The photo on the left is before the treatment. The center photo is of the filaments inside the patient’s used dialyzer. The photo on the right is the patient’s blood immediately after the treatment.
Lab Results – Heavy Metals Removed by Dialyzer
Patient 1167 – Blood Pre-EBOO /F and Blood Post-EBOO /F
Aluminum, arsenic, cadmium, lead and mercury were significantly reduced in the patient’s blood following treatment with the EBOO/F device.
Lab analysis of heavy metals present in patient’s blood Pre and Post EBOO /F treatment. Most, if not all, were reduced.
Patient 1168 – Blood Pre-EBOO /F and Blood Post-EBOO /F
Aluminum, arsenic, lead and mercury were significantly reduced in the patient’s blood following treatment with the EBOO/F device.
Lab analysis of heavy metals present in patient’s blood Pre and Post EBOO /F treatment. Most, if not all, were reduced.
Patient 1169 – Blood Pre-EBOO /F and Blood Post-EBOO /F
Aluminum, arsenic, cadmium, and lead were significantly reduced in the patient’s blood following treatment with the EBOO/F device.
Lab analysis of heavy metals present in patient’s blood Pre and Post EBOO /F treatment. Most, if not all, were reduced.
Explore the photos below to get an in-depth view of the EBOO /F Ozone Therapy (apheresis) Treatment.
Extracorporeal Blood Oxygenation, Ozonation and Filtration FAQs
Q. Is the EBOO /F the same as plasmapheresis?
A. There are numerous forms of Apheresis depending on what exactly is being filtered out of the blood. Plasmapheresis is one of these forms.
The Apheresis device we are using is specifically designed to filter out of the blood, debris left over from chronic infections, such as endotoxins, particles of killed bacteria, cellular debris from damaged tissues, etc.
Q. How much blood is filtered through the EBOO /F device?
A. The procedure takes approximately an hour. In that time between 4 – 5 liters of blood are filtered.
The typical adult has on average 4.5-5.5 liters of blood.
Q. What does the EBOO /F filter out of the blood?
A. Physical debris left over from chronic infections and systemic inflammation.
This includes:
- Endotoxins, which are fragments of pathogenic bacteria, fungus and mold infections that have been killed.
- Biofilm, which is a kind of sludge that many pathogenic microbes create to hide in… and where our immune cells can not penetrate.
- Debris from our own tissues that have been damaged from the infecting microbes and/or from powerful antimicrobial pharmaceutical drugs.
- Micro clots – microscopic blood clots that are resistant to the body’s own fibrinolytic processes.
Our kidneys and liver, which are extremely efficient in cleaning our blood from chemical toxins, are not good at cleaning the physical debris listed above.
Q. Why do some people do chelation before the EBOO /F and some don’t?
A. As mentioned, the human body is not good at filtering the blood to get rid of toxic debris from chronic infections (see answer above). But to leave these toxic materials in the blood can make a person quite sick, and unable to function.
The body deals with this by storing these toxins in our tissues, and out of circulation. Tissues such as fat can store an enormous amount of toxic substances, including drugs and medications.
Additionally, all of our tissues are constructed within a system of Extracellular Matrix which holds our cells together. This ExtraCellular Matrix is designed to store an enormous amount of toxins away from the blood.
Chelation therapy is designed to “shake loose” these toxins out of the tissues and back into the blood, where they can be successfully filtered and removed from your body.
Q. What kind of chelation is used?
A. Typically, IV chelation with a substance called EDTA is used. A great “side-benefit” derived from using chelation therapy is detoxification from Heavy Metals.
Q. How many EBOO /F treatments do I need?
A. Depends on what condition your body is dealing with.
As a reference, our patients who are suffering from chronic Lyme symptoms even after a successful Lyme “kill”, generally need 4-6 sessions, once per week. Their results are best if they have a chelation IV early in the week and their EBOO /F treatment 2-3 days later.
Q. Is this a cure?
A. In the USA, it is forbidden to say that a treatment is a “cure” for a condition if it has not been validated by the FDA. Thus we can not use the “cure” word no matter how effective the EBOO /F treatment is.
What we can say is: that the clinical results of using EBOO /F as a treatment for certain ailments is very effective compared to all other conventional treatments.
Q. Are both arms used during the EBOO /F treatment?
A. Yes. The blood comes out of one arm and the filtered blood is returned via the other arm.
Q. Can I still do EBOO /F if I’ve had breast cancer in the past?
A. Yes.
Q. Do I need to do anything to prepare for the EBOO /F treatment?
A. No. However, it would be helpful if you have had a blood test for the presence of the enzyme G6PD.
Q. How will I feel after the EBOO /F treatment?
A. Most patients feel significantly better even during the treatment! Brain fog clears, energy comes back.
Q. Can I drive after the EBOO /F treatment?
A. Yes.
Q. Any precautions I should know about?
A. If you have any kind of abnormal blood issues or bleeding issues, clotting, etc, we need to know about them.
Q. Can anybody do it?
A. Almost anybody. The main challenge is with people who have very poor veins, that are difficult to get good IV access.
Learn More About the Science of EBOO /F and Ozone Therapy
References - Read the Science...
Everything on our website comes from from reputable publications, books and scientific journals, most of which are available on PubMed and other government websites. These include Meta-Analysis’, Randomized Controlled Trials, Clinical Trials, Systematic Reviews, Books and Documents. We encourage you to read the science, in order to separate fact from fiction, so that you can arrive at a full understanding of what is best for your body. We would be honored to be a part of that educational journey with you.
- Rowen RJ, Grabovac S, Su TB. Ozone dialysis delivers three or more times the ozone than other forms of ozone blood treatment. Med Gas Res. 2023 Apr-Jun;13(2):67-71. doi: 10.4103/2045-9912.356474. PMID: 36204785; PMCID: PMC9555023.
- N Di Paolo, E Gaggiotti, F Galli. Extracorporeal blood oxygenation and ozonation: clinical and biological implications of ozone therapy. 2005;10(3):121-30
- N Di Paolo, V Bocci, D P Salvo, G Palasciano, M Biagioli, S Meini, F Galli, I Ciari, F Maccari, F Cappelletti, M Di Paolo, E Gaggiotti. Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease. 2005 Oct;28(10):1039-50.
- Di Paolo N, Bocci V, Cappelletti F, Petrini G, Gaggiotti E. Necrotizing fasciitis successfully treated with extracorporeal blood oxygenation and ozonization (EBOO). 2002 Dec;25(12):1194-8.
- Wu J, Tan CS, Yu H, Wang Y, Tian Y, Shao W, Zhang Y, Zhang K, Shao H, Ni G, Shen J, Galoforo A, Wu Q, Ming D. Recovery of Four COVID-19 Patients via Ozonated Autohemotherapy. 2020 Nov 4:100060.
- Rowen RJ. Ozone and oxidation therapies as a solution to the emerging crisis in infectious disease management: a review of current knowledge and experience. Med Gas Res. 2019 Oct-Dec;9(4):232-237.
- Belianin II, Shmelev EI. [Ozone therapy for protracted pneumonias]. Probl Tuberk Bolezn Legk. 2009;(3):28-33.
- Bocci VA, Zanardi I, Travagli V. Ozone acting on human blood yields a hormetic dose-response relationship. J Transl Med. 2011 May 17;9:66.
- Bocci V, Zanardi I, Travagli V, Di Paolo N. Oxygenation-ozonation of blood during extracorporeal circulation: in vitro efficiency of a new gas exchange device. Artif Organs. 2007 Sep;31(9):743-8.
- Di Paolo N, Bocci V, Garosi G, Borrelli E, Bravi A, Bruci A, Aldinucci C, Capotondo L. Extracorporeal blood oxygenation and ozonation (EBOO) in man. preliminary report. Int J Artif Organs. 2000 Feb;23(2):131-41.
- Moreno-Fernández A, Macías-García L, Valverde-Moreno R, Ortiz T, Fernández-Rodríguez A, Moliní-Estrada A, De-Miguel M. Autohemotherapy with ozone as a possible effective treatment for Fibromyalgia. Acta Reumatol Port. 2019 Sep 29;44(3):244-249.